| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 175 | 591 | 1.466 | 3.329 | 5.342 | 11.026 | 8.777 | 4.265 |
| Total Income - EUR | - | - | 175 | 591 | 1.466 | 3.350 | 5.427 | 11.215 | 9.127 | 4.942 |
| Total Expenses - EUR | - | - | 87 | 645 | 216 | 668 | 1.745 | 3.368 | 5.621 | 5.111 |
| Gross Profit/Loss - EUR | - | - | 88 | -54 | 1.250 | 2.682 | 3.682 | 7.847 | 3.506 | -169 |
| Net Profit/Loss - EUR | - | - | 84 | -71 | 1.206 | 2.590 | 3.522 | 7.517 | 2.968 | -169 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Soanco Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 11.815 | 9.425 | 4.846 |
| Current Assets | - | - | 171 | 96 | 1.425 | 3.980 | 7.458 | 15.638 | 20.803 | 25.001 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 379 | 1.006 | 0 |
| Cash | - | - | 171 | 96 | 1.425 | 3.980 | 7.458 | 15.259 | 8.679 | 12.615 |
| Shareholders Funds | - | - | 128 | 53 | 1.258 | 3.824 | 7.261 | 14.800 | 17.723 | 17.455 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 44 | 43 | 167 | 153 | 197 | 12.653 | 12.505 | 12.392 |
| Income in Advance | - | - | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Soanco Med Srl